Download PDF
Horm Metab Res 2020; 52(11): 769-774
DOI: 10.1055/a-1227-6635
Review

COVID-19 in Children and Adolescents with Endocrine Conditions

Eirini Kostopoulou  ‡
1   Division of Paediatric Endocrinology and Diabetes, University of Patras, Patras, Greece
,
Maria Güemes‡
2   Endocrinology Service, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
,
Pratik Shah 
3   Paediatric Endocrinology and Diabetes, The Royal London Children’s Hospital, London, United Kingdom
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

The rapid spread of coronavirus disease (COVID-19) worldwide justifies global effort to combat the disease but also the need to review effective preventive strategies and medical management for potentially high-risk populations during the pandemic. Data regarding the COVID-19 manifestations in adults with underlying endocrine conditions, especially diabetes mellitus, are increasingly emerging. Albeit children and adolescents are considered to be affected in a milder manner, paucity of information regarding COVID-19 in children who suffer from endocrinopathies is available. The present review comprehensively collects recommendations issued by various health organizations and endocrine associations for the management of pediatric endocrine conditions during the pandemic. Adhering to the specific “sick day management rules” and undelayed seeking for medical advice are only needed in most of the cases, as the vast majority of children with endocrine disorders do not represent a high-risk population for contamination or severe presentation of COVID-19. Psychological implications in these children and adolescents are also considered.

Key words

COVID-19 - pediatrics - endocrine disease - diabetes mellitus - psychological aspects


Publication History

Received: 14 May 2020

Accepted after revision: 20 July 2020

Article published online:
08 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 World Health Organization (WHO). Rolling updates on coronavirus disease (COVID-19). Internet, cited 18 April 2020; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
    PubMed
  • 2 World Health Organization (WHO), Regional Office for Europe. COVID-19: Latest updates. Internet, cited 19 April 2020; Available from: http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/covid-19-latest-updates
    PubMed
  • 3 Dong Y, Mo X, Hu Y. et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145 pii: e20200702, DOI: 10.1542/peds.2020-0702 [Epub ahead of print].
    CrossrefPubMedGoogle Scholar
  • 4 Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA 2020; 323: 1335
    CrossrefPubMedGoogle Scholar
  • 5 Gudbjartsson DF, Helgason A, Jonsson H. et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med 2020; 382: 2302-2315
    CrossrefPubMedGoogle Scholar
  • 6 Promislow DEL. A geroscience perspective on COVID-19 mortality. J Gerontol A Biol Sci Med Sci 2020; pii: glaa094 DOI: 10.1093/gerona/glaa094 [Epub ahead of print].
    CrossrefPubMedGoogle Scholar
  • 7 Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 2020; 323: 2427-2419
    CrossrefPubMedGoogle Scholar
  • 8 Cristiani L, Mancino E, Matera L. et al. Will children reveal their secret? The coronavirus dilemma. Eur Respir J 2020; 2000749 DOI: 10.1183/13993003.00749-2020 [Epub ahead of print].
    CrossrefPubMedGoogle Scholar
  • 9 Cao Q, Chen Y-C. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc 2020; 119: 670-673
    CrossrefPubMedGoogle Scholar
  • 10 Royal College of Paediatrics and Child Health (RCPCH). COVID-19 – ‘shielding’ guidance for children and young people. Internet, cited 20 April 2020; Available from: https://www.rcpch.ac.uk/sites/default/files/generated-pdf/document/COVID-19—%2527shielding%2527-guidance-for-children-and-young-people.pdf
    PubMed
  • 11 Kennedy NA, Jones G, Lamb CA. et al. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut 2020; DOI: 10.1136/gutjnl-2020-321244 [Epub ahead of print].
    CrossrefPubMedGoogle Scholar
  • 12 European Society for Paediatric Endocrinology (ESPE). Coronavirus disease (COVID-19) information for children and adolescents living with endocrine conditions, including type 1 diabetes mellitus. Internet, cited 23 Mar 2020; Available from: https://www.eurospe.org/news/item/14064/COVID-19-information-for-children-and-adolescents-living-with-endocrine-conditions-including-type-1-diabetes-mellitus
    PubMed
  • 13 International Society for Pediatric and Adolescent Diabetes (ISPAD). Coronavirus infection (COVID-19). Summary of recommendations regarding COVID-19 in children with diabetes. Internet, cited 19 Mar 2020; Available from: https://www.ispad.org/page/CoronavirusinfectionCOVID-19
    PubMed
  • 14 Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) clinical care. Internet, cited 30 Mar 2020; Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients
    PubMed
  • 15 International Diabetes Federation. COVID-19 outbreak: guidance for people with diabetes. Internet, cited 15 April 2020; Available from: idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html
    PubMed
  • 16 Puig-domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 2020; 68: 2-5
    CrossrefPubMedGoogle Scholar
  • 17 Rasmussen S, Thompson LA. Coronavirus disease 2019 and children. What Pediatric health care clinicians need to know. JAMA Pediatr 2020; doi: DOI: 10.1001/jamapediatrics.2020.1224.
    CrossrefPubMedGoogle Scholar
  • 18 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720
    CrossrefPubMedGoogle Scholar
  • 19 COVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: Report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020. Internet; Available from: https://www.epicentro.iss.it/ coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf
    PubMed
  • 20 CDC COVID-19 Response Team Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 382-386
    CrossrefPubMedGoogle Scholar
  • 21 Guo W, Li M, Dong Y. et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020; e3319
    PubMedGoogle Scholar
  • 22 Kaiser UB, Mirmira RB, Stewart PM. Our response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab 2020; 105: 1-3
    CrossrefPubMedGoogle Scholar
  • 23 Lazzerini M, Barbi E, Apicella A. et al. Delayed Access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health 2020; 4: e-10-e11
    CrossrefPubMedGoogle Scholar
  • 24 Bancos I, Hazeldine J, Chortis V. et al. Eur J Primary adrenal insufficiency is associated with impaired natural killer cell function: A potential link to increased mortality. Endocrinol 2017; 176: 471-480
    PubMedGoogle Scholar
  • 25 Baldeweg SE, Ball S, Brooke A. et al. Society for Endocrinology clinical guidance: Inpatient management of cranial diabetes insipidus. Endocr Connect 2018; 7: G8-G11
    CrossrefPubMedGoogle Scholar
  • 26 Tomlinson JW, Holden N, Hills RK. et al. Association between premature mor- tality and hypopituitarism. West mid- lands prospective hypopituitary study group. Lancet 2001; 357: 425-431
    PubMedGoogle Scholar
  • 27 British Thyroid Foundation. Thyroid disease and coronavirus (COVID-19). Internet, cited 25 March 2020; Available from: https://www.btf-thyroid.org/news/thyroid-disease-and-coronavirus-covid-19
    PubMed
  • 28 Senniappan S, Alexandrescu S, Tatevian N. et al. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med 2014; 370: 1131-1137
    CrossrefPubMedGoogle Scholar
  • 29 Arlt W. Society for Endocrinology Clinical Committee Society for Endocrinology Endocrine Emergency Guidance: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect 2016; 5: G1-G3
    CrossrefPubMedGoogle Scholar
  • 30 Cushing’s Disease News. Information about COVID-19 for Cushing’s disease patients. Internet, cited 22 April 2020; Available from: https://cushingsdiseasenews.com/information-about-covid-19-for-cushings-disease-patients/
    PubMed
  • 31 Qin J, Deng X, Wei A. Correlation between hypocalcemia and acute exacerbation of chronic obstructive pulmonary disease in the elderly. Postgrad Med 2019; 131: 319-323
    CrossrefPubMedGoogle Scholar
  • 32 Andersen CA, Murphy KE, Fernandez ML. Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr 2016; 7: 66-75
    CrossrefPubMedGoogle Scholar
  • 33 Rundle AG, Park Y, Herbstman JB. et al. COVID-19-Related School Closings and Risk of Weight Gain Among Children. Obesity 2020; 28: 1008-1009
    CrossrefPubMedGoogle Scholar
  • 34 World Health Organization (WHO). Mental health and psychosocial considerations during the COVID-19 outbreak. Internet, cited 18 March 2020; Available from: https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf
    PubMed
  • 35 CDC. Daily life and Coping. Internet, cited 16 April 2020; Available from: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/managing-stress anxiety.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fmanaging-stress-anxiety.html
    PubMed
  • 36 Wei M, Yuan J, Liu Y. et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA 2020; 323: 1313-1314
    CrossrefPubMedGoogle Scholar
  • 37 Tan YP, Tan BY, Pan J. et al. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China. J Clin Virol 2020; 127: 104353
    CrossrefPubMedGoogle Scholar
  • 38 Yuan R, Xu QH, Xia CC. et al. Psychological status of parents of hospitalized children during the COVID-19 epidemic in China. Psychiatry Res 2020; 288: 112953
    CrossrefPubMedGoogle Scholar
  • 39 Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Health 2020; pii: S2352-4642(20)30109-7 DOI: 10.1016/S2352-4642(20)30109-7 [Epub ahead of print].
    CrossrefPubMedGoogle Scholar
  • 40 Public Health England. Guidance for parents and carers on supporting children and young people’s mental health and wellbeing during the coronavirus (COVID-19) pandemic. Internet, cited 21 April 2020; Available from: https://www.gov.uk/government/publications/covid-19-guidance-on-supporting-children-and-young-peoples-mental-health-and-wellbeing/guidance-for-parents-and-carers-on-supporting-children-and-young-peoples-mental-health-and-wellbeing-during-the-coronavirus-covid-19-outbreak
    PubMed
  • 41 Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull 2004; 130: 601-630
    CrossrefPubMedGoogle Scholar
  • 42 Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med 1999; 61: 175-180
    CrossrefPubMedGoogle Scholar
  • 43 Miller GE, Cohen S, Pressman S. et al. Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body?. Psychosom Med 2004; 66: 215-223
    CrossrefPubMedGoogle Scholar
  • 44 Stam H, Hartman EE, Deurloo JA. et al. Young adult patients with a history of pediatric disease: impact on course of life and transition into adulthood. J Adolesc Health 2006; 39: 4-13
    CrossrefPubMedGoogle Scholar
  • 45 Nardi L, Zucchini S, D’Alberton F. et al. Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self and parent-report questionnaires. Pediatr Diabetes 2008; 9: 496-503
    CrossrefPubMedGoogle Scholar
  • 46 Stawski M, Auerbach JG, Barasch M. et al. Behavioural problems of children with chronic physical illness and their sibilings. Eur Child Adolescent Psychiatry 1997; 6: 20-25
    CrossrefPubMedGoogle Scholar